Library

DMNPC

DMNPC is a piperidine-based stimulant with binding affinities of approximately 7.6 nM at SERT, 21 nM at DAT, and 34 nM at NET, making it roughly 2.5 times more potent than cocaine at DAT while retaining SSRI-level SERT affinity. The compound blocks voltage-gated sodium channels similar to cocaine, producing local anesthesia and potential cardiac conduction effects. Users report severe mucosal irritation with intranasal use and caustic effects when administered intravenously. Oral administration provides cleaner effects with less vascular strain. Due to its recent emergence in late 2024, pharmacokinetic data is limited and reagent testing plus fentanyl screening is essential.

Classification

  • Psychoactive: Stimulant
  • Tag: Piperidine
  • Tag: Research-Chemical

Effects

  • Stimulation
  • Physical Euphoria
  • Pupil Dilation
  • Vasoconstriction
  • Increased Heart Rate
  • Teeth Grinding
  • Cognitive Euphoria
  • Focus Enhancement
  • Sociability Enhancement
  • Motivation Enhancement
  • Compulsive Redosing
  • Anxiety
  • Tactile Enhancement
  • Appetite Suppression
  • Light Sensitivity
  • Increased Sexuality
  • Visual And Auditory Hallucinations
  • Increased Libido

Routes of Administration

Oral

Dosage

  • Threshold: 5 mg
  • Light: 5-15 mg
  • Common: 15-40 mg
  • Strong: 40-60 mg
  • Heavy: 60 mg

Duration

  • Onset: 0.25-0.5 h
  • Comeup: 0.25-0.5 h
  • Peak: 0.5-1.5 h
  • Offset: 1-2 h
  • After Effects: 1-6 h

Insufflated

Dosage

  • Threshold: 5 mg
  • Light: 5-15 mg
  • Common: 15-30 mg
  • Strong: 30-50 mg
  • Heavy: 50 mg

Duration

  • Onset: 0.08-0.17 h
  • Comeup: 0.17-0.33 h
  • Peak: 0.5-1.5 h
  • Offset: 1-2 h
  • After Effects: 1-6 h

Intravenous

Dosage

  • Threshold: 2 mg
  • Light: 2-10 mg
  • Common: 10-25 mg
  • Strong: 25-40 mg
  • Heavy: 40 mg

Duration

  • Onset: 0.02-0.08 h
  • Comeup: 0.08-0.17 h
  • Peak: 0.17-0.75 h
  • Offset: 1-2 h
  • After Effects: 1-6 h

Vaporized / Smoked

Dosage

  • Threshold: 5 mg
  • Light: 5-15 mg
  • Common: 15-35 mg
  • Strong: 35-60 mg
  • Heavy: 60 mg

Duration

  • Onset: 0.02-0.08 h
  • Comeup: 0.08-0.17 h
  • Peak: 0.17-0.75 h
  • Offset: 1-2 h
  • After Effects: 1-6 h

Rectal

Dosage

  • Threshold: 5 mg
  • Light: 5-15 mg
  • Common: 15-30 mg
  • Strong: 30-50 mg
  • Heavy: 50 mg

Duration

  • Onset: 0.17-0.33 h
  • Comeup: 0.25-0.5 h
  • Peak: 0.5-1.5 h
  • Offset: 1-2 h
  • After Effects: 1-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

DMNPC - довідник з речовин DrugsPRO

DMNPC: DMNPC is a piperidine-based stimulant with binding affinities of approximately 7.6 nM at SERT, 21 nM at DAT, and 34 nM at NET, making it roughly 2.5 times more potent than cocaine at DAT while retaining SSRI-level SERT affinity. The compound blocks voltage-gated sodium channels similar to coc

Related pages